Pharmafile Logo
Pharmafocus logo
Advanced Search

AstraZeneca

Showing 15 posts of 785 posts found.

Genome image

Big pharma teams with government on genomic research

March 27, 2015
Research and Development, Sales and Marketing AbbVie, Alexion Pharmaceuticals, AstraZeneca, Biogen, Cameron, Dimension Therapeutics, GSK, Genomic, Genomics england, Helomics, Roche, Takeda, UCB, UK, genomes

Ten firms will partner up with Genomics England to develop new diagnostics and treatments for people with rare diseases and …

News
Astrazeneca image

AstraZeneca and Harvard team up for diabetes research

March 25, 2015
Research and Development, Sales and Marketing AZ, AstraZeneca, Havard, cardiovascular, diabetes, metabolic

AstraZeneca is to work with Harvard University’s department of stem cell and regenerative biology to develop new treatments in diabetes. …

News
Breo image

GSK and Theravance see FDA nod for asthma indication

March 20, 2015
Sales and Marketing Advair, AstraZeneca, Dulera, FDA, Foradil, GSK, Merck, Symbicort, Theravance, asthma, breo, budesonide/formoterol fumarate dihydratem, ellipta, fluticasone propionate, formoterol fumarate, mometasone/formoterol

An FDA panel has recommended the approval of asthma treatment Breo Ellipta in adults – but voted against supporting its …

News
Daiichi image

AstraZeneca and Daiichi team up for constipation drug

March 19, 2015
Sales and Marketing AstraZeneca, Daiichi, Movantik, constipation, naloxegol, oic

AstraZeneca and Daiichi Sankyo have signed a deal worth around $825 million to jointly commercialise constipation drug Movantik in the …

News
astrazeneca image

AstraZeneca buoyed by late-stage trial success

March 18, 2015
Sales and Marketing AstraZeneca, copd. asthma, formoterol fumarate, glycopyrronium, ptoo3, respiratory

AstraZeneca’s investigational respiratory drug has posted positive results in a Phase III trial in people with COPD, having found it …

News
Brilinta image

Mixed results for AstraZeneca in high-profile Brilinta study

March 17, 2015
Sales and Marketing American College of Cardiology, AstraZeneca, Brilinta, EMA, FDA, ticagrelor

Experts say AstraZeneca is at risk of ‘diminishing returns’ in the clinical advantages of its blood-thinning drug Brilinta, after it …

News
Merck Serono image

Merck Serono bets on precision medicine

March 11, 2015
Sales and Marketing AstraZeneca, Diagnostics, FDA, Illumina, Merck Serono, opexa, personalised

Merck Serono is looking to expand further into personalised medicine as the company enters into an agreement with Illumina to …

News
AZ image

AstraZeneca completes respiratory deal with Actavis

March 3, 2015
Research and Development, Sales and Marketing Actavis, AstraZeneca, COPD, Daliresp, Tudorza Pressair, aclidinium bromide inhalation powder, respiratory, roflumilast

AstraZeneca has completed its acquisition of Dublin-headquartered firm Actavis with its branded respiratory portfolio deal worth $700 million. The agreement …

News
Actavis image

Actavis and AZ see FDA approval for ‘superbug’ drug

February 27, 2015
Research and Development, Sales and Marketing Actavis, AstraZeneca, Avycaz, FDA, US, ceftazidime/avibactam

Actavis and AstraZeneca’s combo ‘superbug’ drug Avycaz has been shown the green light to treat patients with complicated intra-abdominal infections …

News
AZ image

AstraZeneca enters autoimmune diseases pact with Orca

February 25, 2015
Research and Development, Sales and Marketing AstraZeneca, autoimmune, orca, orphan nuclear receptor gamma inhibitors, psoriasis, retinoic

AstraZeneca has signed a three-year research deal with the UK-based biotech firm Orca to develop treatments for autoimmune diseases. The …

News

UK pharma commits at least ‘one code breach a week’

February 18, 2015
Medical Communications, Sales and Marketing ABPI, AstraZeneca, Bayer, Eli Lilly, GSK, Novartis, Novo Nordisk, PMCPA, Pfizer, code

Pharma companies commit unethical marketing practices on average more than once a week in the UK academic analysis has found. …

News
astrazeneca image

Several board changes at AstraZeneca

February 17, 2015
Sales and Marketing AstraZeneca, Bruce Burlington, Cornelia Bargmann, Graham Chipchase, Rudy Markham

AstraZeneca is conducting a boardroom overhaul as it announces non-executive board changes and retirements ahead of its annual meeting in …

News
AZ image

AstraZeneca loses US Pulmicort patent

February 16, 2015
Sales and Marketing AstraZeneca, Budesonide Inhalation Suspension, asthma, pulmicourt, respiratory

British drugmaker AstraZeneca has been dealt a blow by the courts in the US, after a district judge ruled its …

News
AZ image

AstraZeneca looks for revenue boost via Actavis buy

February 6, 2015
Sales and Marketing Actavis, AstraZeneca, Brilinta, Forxiga, diabetes, fourth quarter, q4

AstraZeneca recorded a dip in revenue in the last quarter of 2014 and is looking to ramp up its respiratory …

News
AZ image

AstraZeneca dives into gene editing

January 29, 2015
Research and Development, Sales and Marketing AstraZeneca, Intellia Therapetics, Novartis, Thermo Fisher Scientific, Wellcome Trust Sanger Institute in Cambridge, Whitehead, broad institute, crispr, the Innovative Genomics Initiative in California

AstraZeneca is looking to harness the power of a pioneering genome-editing tool in a series of new collaborations. The UK …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025